opioids
“We’re losing 300,000 people a year to fentanyl that comes through our border. We had it down to the lowest number and now it’s worse than it’s ever been.” — Former President Donald Trump at a July 24 campaign rally in Charlotte, North Carolina Former President Donald Trump claimed at a recent campaign rally that more than 300,000 Americans are dying each year from the synthetic opioid drug fentanyl, and that the number of fentanyl overdoses was the “lowest” during his administration and has skyrocketed since. “We’re losing 300,000 people a year to fentanyl that comes through our border,” Trum...
Kaiser Health News
“We’re losing 300,000 people a year to fentanyl that comes through our border. We had it down to the lowest number and now it’s worse than it’s ever been.” — Former President Donald Trump at a July 24 campaign rally in Charlotte, North Carolina Former President Donald Trump claimed at a recent campaign rally that more than 300,000 Americans are dying each year from the synthetic opioid drug fentanyl, and that the number of fentanyl overdoses was the “lowest” during his administration and has skyrocketed since. “We’re losing 300,000 people a year to fentanyl that comes through our border,” Trum...
California Healthline
A new meta-analysis of 148 studies estimates that 9.3 percent of patients who receive opioid prescriptions for chronic pain experience "dependence" or "opioid use disorder" (D&OUD). The authors, Kyla Thomas and six other researchers at Bristol Medical School in England, also calculated prevalence rates for "signs and symptoms" of D&OUD (29.6 percent), "aberrant behavior" (22 percent), and those deemed "at risk" of D&OUD (12.4 percent). They conclude that "problematic pharmaceutical opioid use appears to be common in chronic pain patients treated with opioid analgesics, with nearly one in 10 ex...
Reason
SACRAMENTO — Sonja Verdugo lost her husband to an opioid overdose last year. She regularly delivers medical supplies to people using drugs who are living — and dying — on the streets of Los Angeles. And she advocates at Los Angeles City Hall for policies to address addiction and homelessness. Yet Verdugo didn’t know that hundreds of millions of dollars annually are flowing to California communities to combat the opioid crisis, a payout that began in 2022 and continues through 2038. The money comes from pharmaceutical companies that made, distributed, or sold prescription opioid painkillers and...
Kaiser Health News
SACRAMENTO — Sonja Verdugo lost her husband to an opioid overdose last year. She regularly delivers medical supplies to people using drugs who are living — and dying — on the streets of Los Angeles. And she advocates at Los Angeles City Hall for policies to address addiction and homelessness. Yet Verdugo didn’t know that hundreds of millions of dollars annually are flowing to California communities to combat the opioid crisis, a payout that began in 2022 and continues through 2038. The money comes from pharmaceutical companies that made, distributed, or sold prescription opioid painkillers and...
California Healthline
En los últimos dos años, una solicitud simple pero desconcertante ha precedido la mayoría de mis encuentros con profesionales médicos: “Califique su dolor en una escala del cero al 10”. Me formé como médica y he hecho esta misma pregunta a los pacientes miles de veces, así que pienso mucho en cómo cuantificar la suma de caderas doloridas, muslos punzantes y el dolor adormecedor cerca de mi omóplato izquierdo. Hago una pausa y luego, generalmente de manera arbitraria, elijo un número. “¿Tres o cuatro?”, aventuro, sabiendo que la respuesta real es larga, complicada e imposible de medir de esta m...
Kaiser Health News (Espanol)
Over the past two years, a simple but baffling request has preceded most of my encounters with medical professionals: “Rate your pain on a scale of zero to 10.” I trained as a physician and have asked patients the very same question thousands of times, so I think hard about how to quantify the sum of the sore hips, the prickly thighs, and the numbing, itchy pain near my left shoulder blade. I pause and then, mostly arbitrarily, choose a number. “Three or four?” I venture, knowing the real answer is long, complicated, and not measurable in this one-dimensional way. Pain is a squirrely thing. It...
Kaiser Health News
Over the past two years, a simple but baffling request has preceded most of my encounters with medical professionals: “Rate your pain on a scale of zero to 10.” I trained as a physician and have asked patients the very same question thousands of times, so I think hard about how to quantify the sum of the sore hips, the prickly thighs, and the numbing, itchy pain near my left shoulder blade. I pause and then, mostly arbitrarily, choose a number. “Three or four?” I venture, knowing the real answer is long, complicated, and not measurable in this one-dimensional way. Pain is a squirrely thing. It...
California Healthline
Washington (AFP) - The US Supreme Court on Thursday rejected Purdue Pharma's $6 billion opioids settlement immunizing the Sackler family, which controlled the drugmaker, from future litigation. In a 5-4 ruling, the judges agreed with the Justice Department which argued that the Sacklers, who earned tens of billions of dollars flooding the country with highly addictive opioids, should not gain sweeping legal protection in the controversial deal. The court held that "the bankruptcy code does not authorize this kind of order," with the majority opinion written by Neil Gorsuch and joined by Claren...
AFP
After OxyContin manufacturer Purdue Pharma filed for Chapter 11 bankruptcy in 2019, members of the Sackler family, which controlled the company, arranged a resolution that included personal protection from civil liability for contributing to opioid-related deaths. That shield was part of a mass settlement that promised myriad litigants a total of $6 billion. The Supreme Court narrowly rejected that deal today. "The bankruptcy code does not authorize a release and injunction that, as part of a plan of reorganization under Chapter 11, effectively seeks to discharge claims against a nondebtor wit...
Reason
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら